Skip to main content
Clinical Trials/NCT03586102
NCT03586102
Completed
Not Applicable

Effect of Increased Enteral Protein on Body Composition of Preterm Infants: A Randomized Trial

University of Alabama at Birmingham1 site in 1 country56 target enrollmentAugust 23, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Premature Infant
Sponsor
University of Alabama at Birmingham
Enrollment
56
Locations
1
Primary Endpoint
Infant body composition
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

The study hypothesis is that, in human milk-fed extremely preterm infants, higher protein intake compared to usual protein intake reduces percent body fat (%BF) at 3 months of age.

Detailed Description

Qualifying participants will be randomly assigned to receive either standard protein supplementation (control group) or high protein supplementation (intervention group). Intervention group: A fixed amount of commercially available hydrolyzed bovine protein will be added to fortified human milk after establishment of full enteral feeding. Control group: Hydrolyzed bovine protein will not be added to fortified human milk after establishment of full enteral feeding. If parent agrees, stool "dirty" diapers will be collected 2 times (at the time of hospital discharge and at 3 months of corrected age).

Registry
clinicaltrials.gov
Start Date
August 23, 2018
End Date
April 24, 2025
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ariel A. Salas

Assistant Professor

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • Gestational age between 25 and 28 weeks of gestation
  • Feeding volumes of ≥120 ml/kg/day before or on postnatal day 14.

Exclusion Criteria

  • Necrotizing enterocolitis (NEC) stage 2 or greater.
  • Gastrointestinal or neurologic malformations.
  • Terminal illness needing to limit or withhold support will be exclusion criteria.

Outcomes

Primary Outcomes

Infant body composition

Time Frame: Assessed at 36 weeks of postmenstrual age or at 3 months of corrected age

Percent body fat estimated by air displacement plethysmography

Secondary Outcomes

  • Length(Birth to 3 months of corrected age)
  • Necrotizing enterocolitis(Postnatal day 14 to postnatal day 120 or discharge, whichever occurs first)
  • Infant body composition(Assessed at 36 weeks of postmenstrual age or hospital discharge (whichever occurs first))
  • Body mass index(Birth to 3 months of corrected age)
  • Growth(Birth to 3 months of corrected age)
  • Head circumference(Birth to 3 months of corrected age)
  • Death(Postnatal day 14 to postnatal day 120 or discharge, whichever occurs first)

Study Sites (1)

Loading locations...

Similar Trials